Takahiro Ito

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Binding Protein

Top Venues

Life science alliance

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ruochong Wang, Futaba Kato, Rio Yasui Watson, Aaron M Beedle, Jarrod A Call, Yugo Tsunoda, Takeshi Noda, Takaho Tsuchiya, Makoto Kashima, Ayuna Hattori, Takahiro Ito
The RNA-binding protein Msi2 regulates autophagy during myogenic differentiation. Life science alliance 7 (5) (2024)
Ruochong Wang, Futaba Kato, Rio Yasui Watson, Aaron M Beedle, Jarrod A Call, Yugo Tsunoda, Takeshi Noda, Takaho Tsuchiya, Makoto Kashima, Ayuna Hattori, Takahiro Ito
The RNA-binding protein Msi2 regulates autophagy during myogenic differentiation. Life science alliance 7 (5) (2024)
Ruochong Wang, Futaba Kato, Rio Yasui Watson, Aaron M Beedle, Jarrod A Call, Yugo Tsunoda, Takeshi Noda, Takaho Tsuchiya, Makoto Kashima, Ayuna Hattori, Takahiro Ito
The RNA-binding protein Msi2 regulates autophagy during myogenic differentiation. Life science alliance 7 (5) (2024)
Koji Jimbo, Yaeko Nakajima-Takagi, Takahiro Ito, Shuhei Koide, Yasuhito Nannya, Atsushi Iwama, Arinobu Tojo, Takaaki Konuma
Immunoglobulin superfamily member 8 maintains myeloid leukemia stem cells through inhibition of β-catenin degradation. Leukemia 36 (6) (2022)
Koji Jimbo, Ayuna Hattori, Shuhei Koide, Takahiro Ito, Katsuhiro Sasaki, Kazuhiro Iwai, Yasuhito Nannya, Atsushi Iwama, Arinobu Tojo, Takaaki Konuma
Genetic deletion and pharmacologic inhibition of E3 ubiquitin ligase HOIP impairs the propagation of myeloid leukemia. Leukemia (2022)
Kyle Spinler, Jeevisha Bajaj, Takahiro Ito, Bryan Zimdahl, Michael Hamilton, Armin Ahmadi, Claire S Koechlein, Nikki Lytle, Hyog Young Kwon, Ferdous Anower-E-Khuda, Hao Sun, Allen Blevins, Joi Weeks, Marcie Kritzik, Jan Karlseder, Mark H Ginsberg, Pyong Woo Park, Jeffrey D Esko, Tannishtha Reya
A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia. Nature communications 11 (1) (2020)